{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:46:25Z","timestamp":1791150385473,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,24]]},"DOI":"10.1097\/qad.0b013e32832d3b6d","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T15:49:22Z","timestamp":1250178562000},"page":"1717-1725","source":"Crossref","is-referenced-by-count":269,"title":["Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa"],"prefix":"10.1097","volume":"23","author":[{"given":"Stephen D","family":"Lawn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon","family":"Myer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210130","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study","volume":"282","author":"Ledergerber","year":"1999","journal-title":"JAMA"},{"key":"R2-11-20210130","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1164\/ajrccm.162.3.9908018","article-title":"Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD","volume":"162","author":"Kirk","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-11-20210130","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","article-title":"Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection","volume":"14","author":"Girardi","year":"2000","journal-title":"AIDS"},{"key":"R4-11-20210130","first-page":"1026","article-title":"HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult\/Adolescent Spectrum of HIV Disease Group","volume":"4","author":"Jones","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"R5-11-20210130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R6-11-20210130","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"R7-11-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","article-title":"Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan","volume":"172","author":"Seyler","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-11-20210130","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R9-11-20210130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"key":"R10-11-20210130","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/01.aids.0000232235.26630.ee","article-title":"Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden","volume":"20","author":"Bonnet","year":"2006","journal-title":"AIDS"},{"key":"R11-11-20210130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda","volume":"21","author":"Moore","year":"2007","journal-title":"AIDS"},{"key":"R12-11-20210130","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":"Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa","volume":"22","author":"Lawn","year":"2008","journal-title":"AIDS"},{"key":"R13-11-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2217\/17469600.1.4.387","article-title":"Concurrent drug therapy for tuberculosis and HIV infection in resource-limited settings: present status and future prospects","volume":"1","author":"Lawn","year":"2007","journal-title":"Future HIV Ther"},{"issue":"Suppl 1","key":"R14-11-20210130","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1086\/518661","article-title":"Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment","volume":"196","author":"Bock","year":"2007","journal-title":"J Infect Dis"},{"key":"R15-11-20210130","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"R16-11-20210130","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1126\/science.1086845","article-title":"Antiretroviral drugs for tuberculosis control in the era of HIV\/AIDS","volume":"301","author":"Williams","year":"2003","journal-title":"Science"},{"key":"R17-11-20210130","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/01.aids.0000176211.08581.5a","article-title":"How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R19-11-20210130","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.aids.0000176221.33237.67","article-title":"Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?","volume":"19","author":"Breen","year":"2005","journal-title":"AIDS"},{"key":"R20-11-20210130","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.200709-1311PP","article-title":"Immune reconstitution and \u2018unmasking\u2019 of tuberculosis during antiretroviral therapy","volume":"177","author":"Lawn","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R21-11-20210130","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1097\/01.aids.0000194802.89540.e1","article-title":"Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R22-11-20210130","first-page":"315","article-title":"Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa","volume":"96","author":"Bekker","year":"2006","journal-title":"S Afr Med J"},{"key":"R24-11-20210130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/135965350701200106","article-title":"Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited","volume":"12","author":"Orrell","year":"2007","journal-title":"Antivir Ther"},{"key":"R25-11-20210130","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/507095","article-title":"Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation","volume":"43","author":"Lawn","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R27-11-20210130","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R28-11-20210130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","article-title":"Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals","volume":"5","author":"Lawn","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R29-11-20210130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/sti.79.4.337","article-title":"Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy","volume":"79","author":"Goldsack","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R30-11-20210130","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/01.aids.0000191922.08938.12","article-title":"Response to \u2018Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?\u2019","volume":"19","author":"John","year":"2005","journal-title":"AIDS"},{"key":"R31-11-20210130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/QAD.0b013e32831d2a98","article-title":"Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organising pneumonia: the role of macrophages","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"R33-11-20210130","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1086\/429825","article-title":"High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania","volume":"40","author":"Mtei","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R34-11-20210130","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1371\/journal.pmed.0040022","article-title":"Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease","volume":"4","author":"Corbett","year":"2007","journal-title":"PLoS Med"},{"key":"R35-11-20210130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1164\/rccm.200606-759OC","article-title":"Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control","volume":"175","author":"Wood","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R36-11-20210130","first-page":"523","article-title":"Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa","volume":"10","author":"Day","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"R37-11-20210130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2334-6-59","article-title":"CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa","volume":"6","author":"Lawn","year":"2006","journal-title":"BMC Infect Dis"},{"key":"R39-11-20210130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e328321823f","article-title":"Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"R40-11-20210130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1473-3099(06)70463-7","article-title":"Immunological recovery and antiretroviral therapy in HIV-1 infection","volume":"6","author":"Battegay","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R41-11-20210130","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/501018","article-title":"Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions","volume":"42","author":"Lawn","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R42-11-20210130","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"},{"issue":"Suppl 1","key":"R43-11-20210130","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/518662","article-title":"Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities","volume":"196","author":"Churchyard","year":"2007","journal-title":"J Infect Dis"},{"key":"R44-11-20210130","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0040298","article-title":"Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review","volume":"4","author":"Rosen","year":"2007","journal-title":"PLoS Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200908240-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:08:12Z","timestamp":1786039692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200908240-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,24]]},"references-count":39,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32832d3b6d","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8,24]]}}}